Pay in 4 interest-free payments of $6.79 Learn more
.png.jpg)
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Tirzepatide acts on GIP and GLP-1 receptors to help control insulin release and appetite
Footnotes 1.^ References 1
In addition, AbbVie provides a Botox Savings Program which will cover $1000 of any out of pocket costs per treatment and $4000 per year
Compounded retatrutide from research suppliers often has shorter in-use limits because of variable formulation
Retatrutide is not yet approved anywhere and remains investigational, with an NDA filing anticipated later in 2026 based on the current trial timeline
US$ 22.96
US$ 23.63
US$ 20.32
